SCHEDULE 13GFiled May 28, 8:00 PM ET

BridgeBio Pharma, Inc. SCHEDULE 13G

Farallon Capital Partners, L.P.

Summary not available

This filing does not have a generated research summary. You can still open the original filing and its exhibits.